1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
- Contribution to journal › Article
-
Mark
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer : A study protocol of ARIADNE
- Contribution to journal › Article
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
- Contribution to journal › Article
- 2021
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
- Contribution to journal › Article
-
Mark
Sample preparation approach influences pam50 risk of recurrence score in early breast cancer
- Contribution to journal › Article
-
Mark
Disseminated tumour cells from the bone marrow of early breast cancer patients : Results from an international pooled analysis
- Contribution to journal › Article
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
- Contribution to journal › Article
- 2019
-
Mark
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
- Contribution to journal › Article
